DE60133396D1 - Modifizierte zellen und ihre verwendungen, insbesondere zur herstellung von steroidderivate - Google Patents

Modifizierte zellen und ihre verwendungen, insbesondere zur herstellung von steroidderivate

Info

Publication number
DE60133396D1
DE60133396D1 DE60133396T DE60133396T DE60133396D1 DE 60133396 D1 DE60133396 D1 DE 60133396D1 DE 60133396 T DE60133396 T DE 60133396T DE 60133396 T DE60133396 T DE 60133396T DE 60133396 D1 DE60133396 D1 DE 60133396D1
Authority
DE
Germany
Prior art keywords
manufacture
modified cells
steroid derivatives
steroid
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60133396T
Other languages
English (en)
Other versions
DE60133396T2 (de
Inventor
Bruno Dumas
Gilles Cauet
Tilman Achstetter
Eric Degryse
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Aventis Pharma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma SA filed Critical Aventis Pharma SA
Application granted granted Critical
Publication of DE60133396D1 publication Critical patent/DE60133396D1/de
Publication of DE60133396T2 publication Critical patent/DE60133396T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • C12N9/0083—Miscellaneous (1.14.99)
    • C12N9/0087—Steroid 21-monooxygenase (1.14.99.10)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00—Preparation of steroids
    • C12P33/06—Hydroxylating

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
DE60133396T 2000-08-08 2001-07-24 Modifizierte zellen und ihre verwendungen, insbesondere zur herstellung von steroidderivate Expired - Lifetime DE60133396T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0010437 2000-08-08
FR0010437A FR2812884B1 (fr) 2000-08-08 2000-08-08 Levures modifiees et utilisations, notamment pour la production de derives steroidiens
PCT/FR2001/002417 WO2002012536A1 (fr) 2000-08-08 2001-07-24 Levures modifiees et utilisations, notamment pour la production de derives steroidiens

Publications (2)

Publication Number Publication Date
DE60133396D1 true DE60133396D1 (de) 2008-05-08
DE60133396T2 DE60133396T2 (de) 2009-07-09

Family

ID=8853403

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60133396T Expired - Lifetime DE60133396T2 (de) 2000-08-08 2001-07-24 Modifizierte zellen und ihre verwendungen, insbesondere zur herstellung von steroidderivate

Country Status (22)

Country Link
US (2) US7879592B2 (de)
EP (1) EP1313873B1 (de)
JP (1) JP4864277B2 (de)
KR (1) KR100860702B1 (de)
AR (1) AR030080A1 (de)
AT (1) ATE390479T1 (de)
AU (2) AU7856201A (de)
BR (1) BRPI0113048B8 (de)
CA (1) CA2418370C (de)
CY (1) CY1108080T1 (de)
DE (1) DE60133396T2 (de)
DK (1) DK1313873T3 (de)
ES (1) ES2300347T3 (de)
FR (1) FR2812884B1 (de)
IL (2) IL154294A0 (de)
MX (1) MXPA03000702A (de)
NO (1) NO334484B1 (de)
NZ (1) NZ523612A (de)
PT (1) PT1313873E (de)
TW (1) TWI315739B (de)
WO (1) WO2002012536A1 (de)
ZA (1) ZA200300376B (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2812884B1 (fr) * 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) * 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome
FR2976949B1 (fr) * 2011-06-21 2015-08-28 Sanofi Sa Procede de preparation de levures genetiquement transformees capables de produire une molecule d'interet a haut titre

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5571250A (en) 1978-11-22 1980-05-29 Hatano Kk Paper for paper box with lid and method of assembling paper box with lid by using same
CA1159754A (en) 1980-06-27 1984-01-03 Roxane N. Dikeman Process for preparing limulus lysate
JPS62181571A (ja) 1986-08-11 1987-08-08 Canon Inc 画像処理装置
JPS63181571A (ja) 1987-01-22 1988-07-26 Matsushita Electric Ind Co Ltd 自動焦点整合装置
JPS6447380A (en) 1987-08-19 1989-02-21 Agency Ind Science Techn Steroid-oxidizing yeast strain
JPS6471250A (en) 1987-09-11 1989-03-16 Nec Corp Multi-function telephone set
EP0340878B1 (de) 1988-05-06 2001-05-16 Aventis Pharma S.A. Verfahren zur biochemischen Oxidation von Steroiden sowie dafür verwendbare, genetisch manipulierte Zellen
JPH0231680A (ja) * 1988-07-22 1990-02-01 Agency Of Ind Science & Technol チトクロムＰ４５０ｃ↓２↓１産生酵母菌株
CN1042567A (zh) 1988-09-23 1990-05-30 吉斯特-布罗卡迪斯公司 类固醇多步氧化方法和所用的遗传工程细胞
JPH02249488A (ja) * 1989-03-22 1990-10-05 Sumitomo Chem Co Ltd チトクロムＰ４５０↓ｃ↓２↓１と酵母ＮＡＤＰＨ‐チトクロムＰ４５０還元酵素の融合酸化酵素、該酵素をコードする遺伝子および該酵素の製造方法
JP2645130B2 (ja) 1989-03-31 1997-08-25 日清製粉株式会社 ステロイド誘導体
FR2678611B1 (fr) 1991-07-04 1995-01-20 Roussel Uclaf Nouveaux esters pyrethrinouides de l'alcool 1,3,4,5,6,7-hexahydro 1,3-dioxo-2h-isoindol-2-yl-methylique, leur procede de preparation et leur application comme pesticides.
JP3363197B2 (ja) 1992-06-18 2003-01-08 麒麟麦酒株式会社 アルコールアセチルトランスフェラーゼ遺伝子およびその利用
US5547868A (en) 1993-06-09 1996-08-20 Regents Of The University Of California Cholesterol disposal fusion enzymes
IL116872A (en) 1995-02-15 2004-12-15 Aventis Pharma Sa Delta 5,7-Strol Reductase from Arbidopsis Thaliana
JP4093598B2 (ja) 1995-03-14 2008-06-04 大関株式会社 新規なアルコールアセチルトランスフェラーゼ遺伝子
DE19744212B4 (de) 1997-09-30 2006-01-19 Schering Ag Verfahren zur Herstellung von Ergosterol und dessen Zwischenprodukten mittels rekombinanter Hefen
US6303302B1 (en) * 1997-11-19 2001-10-16 The Whitehead Institute For Biomedical Research Regulation of fungal gene expression
FR2774393B1 (fr) 1998-02-05 2000-03-24 Hoechst Marion Roussel Inc Souches de levure ayant le gene atf2 interrompu et leurs applications
FR2799206A1 (fr) 1999-10-05 2001-04-06 Transgene Sa Procede de production de steroides modifies par fermentation de levures
FR2812884B1 (fr) 2000-08-08 2002-11-08 Aventis Pharma Sa Levures modifiees et utilisations, notamment pour la production de derives steroidiens
FR2820145B1 (fr) 2001-01-31 2004-01-23 Aventis Pharma Sa Souche de levure produisant des steroides de facon autonome

Also Published As

Publication number Publication date
US8173402B2 (en) 2012-05-08
KR20030024842A (ko) 2003-03-26
PT1313873E (pt) 2008-05-27
ATE390479T1 (de) 2008-04-15
KR100860702B1 (ko) 2008-09-26
US20110104749A1 (en) 2011-05-05
US7879592B2 (en) 2011-02-01
JP2004505634A (ja) 2004-02-26
CY1108080T1 (el) 2014-02-12
WO2002012536A1 (fr) 2002-02-14
DK1313873T3 (da) 2008-07-14
DE60133396T2 (de) 2009-07-09
BRPI0113048B1 (pt) 2015-12-22
AR030080A1 (es) 2003-08-13
EP1313873A1 (de) 2003-05-28
AU2001278562B2 (en) 2006-07-20
ES2300347T3 (es) 2008-06-16
NO334484B1 (no) 2014-03-17
MXPA03000702A (es) 2003-06-04
TWI315739B (en) 2009-10-11
NO20030606D0 (no) 2003-02-07
JP4864277B2 (ja) 2012-02-01
FR2812884B1 (fr) 2002-11-08
FR2812884A1 (fr) 2002-02-15
NO20030606L (no) 2003-02-07
CA2418370C (fr) 2014-03-11
IL154294A0 (en) 2003-09-17
NZ523612A (en) 2004-11-26
BR0113048A (pt) 2003-07-01
US20040082025A1 (en) 2004-04-29
BRPI0113048B8 (pt) 2021-05-25
ZA200300376B (en) 2004-01-22
EP1313873B1 (de) 2008-03-26
AU7856201A (en) 2002-02-18
IL154294A (en) 2010-05-31
CA2418370A1 (fr) 2002-02-14

Similar Documents

Publication Publication Date Title
DE60101414D1 (de) Hydraulikspeicherentlüftung und ihre Herstellung
DE60137039D1 (de) Verschiebung von verschlüssen zur herstellung von windeln
DE60121609D1 (de) Modifiziertes polyolefinharz, modifizierte polyolefinharzzusammensetzung und ihre verwendung
EE200200613A (et) 3-lämmastik-6,7-dihapniksteroidid ja nende kasutamine
DE60238576D1 (de) Zusammensetzung zur Herstellung von Elektroden und Elektroden
DE60217203D1 (de) Poröse Teilchen, wässrige Dispersionen und Verfahren zu ihrer Herstellung
DE60205047D1 (de) Poröse Teilchen, wässrige Dispersionen und Verfahren zu ihrer Herstellung
DE10084441T1 (de) Koalinton-Pigmente, ihre Herstellung und Verwendung
DE60235632D1 (de) Bicyclische verbindung, deren herstellung und verwendung
DE60019578D1 (de) Polyolefin und die herstellung davon
DE60130834D1 (de) Zusammensetzungen gegen schlechte Gerüche, deren Herstellung und Verwendung
DE60107859D1 (de) Benzimidazolderivate, ihre herstellung und therapeutische verwendung
ID28997A (id) Kedok sekali pakai, dan proses pembuatannya
DE60235547D1 (de) En daraus, deren herstellung und verwendung
DE60001307D1 (de) Pyridopyranoazepinderivate, ihre herstellung und therapeutische verwendung
DE60111430D1 (de) Hypochlorige säure zusammensetzung und ihre verwendungen
DE50207011D1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
DE60227718D1 (de) Verwendung von 2-Fuoro-3-Ketoestern zur Herstellung von 3-Fuoro-6,7,8,9-tetrahydro-4H-pyrimidoÄ1,2-aÜpyrimidin-4-onen
ATE357448T1 (de) Benzoxazinonderivative, deren herstellung und verwendung
ID28820A (id) Komposisi penolak air, proses pembuatan dan pemakainnya
DE60112411D1 (de) Dispergierende aufschlämmung zur herstellung von spandex
ATE533768T1 (de) Imidazol-derivate, ihre herstellung und ihre verwendung
ATE242197T1 (de) 3-amino-3-arylpropan-1-ol-derivate, deren herstellung und verwendung
DE60208044D1 (de) Acylaminothiazolderivate, deren herstellung und deren therapeutische verwendung
DE60114115D1 (de) Bimodale polymerzusammensetzungen mit hohem Feststoffanteil, ihre Herstellung und Verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition